← Back to Search

Active for Neurological Disorders

Phase 1
Waitlist Available
Research Sponsored by Forest Hills Lab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days
Awards & highlights

Study Summary

This trial studies the effects of two drugs on safety and how they are absorbed and used by the body.

Eligible Conditions
  • Neurological Disorders

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Electrocardiogram
Laboratory Results
Physical Results
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ActiveExperimental Treatment1 Intervention
Active Comparator
Group II: PlaceboPlacebo Group1 Intervention
Placebo Comparator
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Glyceryl Tribenzoate
2022
Completed Phase 1
~40

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

LiberyxUNKNOWN
Forest Hills LabLead Sponsor
2 Previous Clinical Trials
132 Total Patients Enrolled

Media Library

Active Clinical Trial Eligibility Overview. Trial Name: NCT05938452 — Phase 1
Neurological Disorders Research Study Groups: Active, Placebo
Neurological Disorders Clinical Trial 2023: Active Highlights & Side Effects. Trial Name: NCT05938452 — Phase 1
Active 2023 Treatment Timeline for Medical Study. Trial Name: NCT05938452 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are mature adults being enlisted for this experiment?

"This clinical trial seeks to enrol participants that have reached the age of majority and are below their fiftieth birthday."

Answered by AI

Is this experiment still open for recruitment?

"The clinical trial is currently accepting candidates. As indicated on clinicaltrials.gov, the study was originally listed in December of 2022 and last updated July 3rd 2023."

Answered by AI

What are the eligibility criteria for participating in this clinical experiment?

"The prerequisites to enter this neurological study is a disorder afflicting the nervous system and being between 18-50 years of age. Approximately 40 participants are sought for the trial."

Answered by AI

What safety measures have been taken to ensure the efficacy of Active for those undergoing treatment?

"Limited evidence of efficacy and safety has resulted in Active being assessed as a 1 on our team's scale. This is because we are currently in the first phase of trials for this medication."

Answered by AI

What is the scope of recruitment for this experiment?

"Affirmative. Data on clinicaltrials.gov verify that this medical experiment, which was first listed on December 12th 2022, is actively recruiting patients. Approximately 40 volunteers need to be enrolled from a single facility."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Safety and Tolerability of Glyceryl Tribenzoate (GTB) Capsules in Healthy Subjects
2022. "Safety and Tolerability of Glyceryl Tribenzoate (GTB) Capsules in Healthy Subjects". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05938452.
~17 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top